BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2009
View Archived Issues
Novel anti-EGFR antibody GA-201 active in tumor models
Read More
P53-armed oncolytic adenovirus CGCT-04 induces apoptosis in cancer cells
Read More
Studies explore pharmacokinetics, antitumor activity of novel formulation of SN-38
Read More
Roche reviews Q1 activity
Read More
Speedel describes novel renin inhibitors as antihypertensive agents
Read More
Ark Therapeutics enrolls first patient into phase III study of Trinam in end-stage renal disease
Read More
SemBioSys' reports results from preclinical studies of plant-derived Apo AI(Milano)
Read More
Prospect Therapeutics to action off assets in June 2009
Read More
Rexahn enrolls 50% of patients in phase IIa trial of Serdaxin in MDD
Read More
Albert Einstein School of Medicine to conduct study of nanoviricide in HSV keratitis
Read More
Koronis SAB confirms positive results from studies of HIV drug KP-1461
Read More
Celator and Cephalon enter agreement in drug development and life-cycle management
Read More
Merck & Co. discovers novel quinolizidinone compounds for the treatment of Alzheimer's disease
Read More
Novartis presents novel ALK5 inhibitors for the treatment of liver fibrosis
Read More
Ferrer claims melatonin receptor agonists for the treatment of sleep disorders
Read More
Schering-Plough describes novel kinesin spindle protein inhibitors for cancer treatment
Read More
Oritavancin efficacy detailed in ECCMID presentations
Read More
Novel monobactam antibiotic BAL-0030072 shows potent activity against multiresistant bacteria
Read More
Aerie Pharmaceuticals reports on discovery and preclinical activity of glaucoma agent AR-12286
Read More
Fusion protein KH-902 well tolerated in patients with choroidal neovascularization
Read More
Vical advances H1N1 pandemic influenza (swine flu) vaccine program
Read More
FDA accepts for review SkyePharma's NDA for Flutiform in persistent asthma
Read More
Johnson & Johnson to acquire Cougar Biotechnology
Read More
Health Canada approves PolyMedix's CTA for phase Ib clinical study of PMX-30063
Read More
Genzyme submits information requested by FDA for Lumizyme
Read More
Human Genome Sciences submits BLA to FDA for ABthrax inhalation anthrax treatment
Read More